Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q4 2022 call → NOWe need to determine if management describes the company as currently living through a defined waiting period it is paying for out of its own pocket, with a specific near-dated event that ends the wait, and that this is the main current work. Let's analyze the transcript. Management discusses various investments: new locations, technology, acquisitions, etc. But we need a specific situation where they are paying now for something not yet earning, and the end is near-dated and visible. Key points: They mention opening new sales centers, greenfields, and investments in technology like POOL360 water solution software launching in 2023. They also mention inventory build-up due to supply chain, but that's more about normalizing. They talk about capacity creation investments. However, is there a specific "waiting period" where they are bearing costs for something not yet earning? For example, they opened 10 new locations in 2022, and those are likely already earning. They mention "we will begin launching our POOL360 water solution software in 2023 for our independent retail dealers" - that's a launch, but is it a cost currently being borne? They say "we have refreshed our brands, and we'll begin launching..." That suggests they are investing in development, but not necessarily a defined waiting period with costs currently landing. They also mention "we continue to enhance our capabilities as we integrated Porpoise Pool & Patio" - that acquisition was in 2021, so integration is ongoing, but they said it's on track with expectations. Not a waiting period. They talk about "capacity creation" and "new sales center development" - but those are ongoing investments, not a single defined waiting period. The question asks for a specific phenomenon: paying now for something not yet earning, with a near-dated event. Management does not seem to describe such a situation. They describe normal growth investments, but not a defined interval where they are bearing costs with no benefit yet, and the end is a specific event. They do mention inventory normalization: they have extra inventory due to supply chain, and they expect to reduce it by end of second/third quarters. But that's not a cost they are paying for something not yet earning; it's just working capital. They also mention import duties and taxes on chemicals, but that's a one-time cost, not a waiting period.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.